leadf
logo-loader
NASDAQ:CODX

Co-Diagnostics

Receive alerts
Market:
NASDAQ
Market Cap:
$373.5 m
Price
13.30 USD
Change
-2.35%
52 weeks high
30.99
52 weeks low
0.86

In brief

At Co-Diagnostics, we are passionate about providing the most robust and innovative molecular tools for detection of infectious diseases in humans, mosquitoes, and animals, liquid biopsy for cancer screening, and agricultural applications, especially to those regions where pricing is paramount. Our proprietary molecular diagnostics technology is paving the way for innovation in disease detection and life sciences research through our enhanced detection of genetic material. Because we own our platform, we are able to accomplish this faster and more economically, allowing for wider margins while still positioning Co-Diagnostics to be the worldwide low-cost leader of molecular diagnostics services.

Snapshot

The Utah company's in-vitro Logix Smart Coronavirus Disease 2019 (COVID-19) test kits are available in nearly 50 countries